Another condition reported was elevated soluble ICAM 1 found in the serum of patients with thyroid cancer (39), which might neutralize anti-ICAM 1-CAR T-cells in the periphery before recognizing ICAM 1+ tumor cells. Here, ICAM1 is linked to neoplasm.